{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:32:23Z","timestamp":1779935543656,"version":"3.53.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T00:00:00Z","timestamp":1225152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1038\/cr.2008.294","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T12:46:03Z","timestamp":1225197963000},"page":"1105-1113","source":"Crossref","is-referenced-by-count":121,"title":["PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production"],"prefix":"10.1038","volume":"18","author":[{"given":"Dahai","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beichu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,10,28]]},"reference":[{"key":"BFcr2008294_CR1","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1046\/j.1365-2567.2003.01684.x","volume":"109","author":"JS Oxford","year":"2003","unstructured":"Oxford JS, Bossuyt S, Lambkin R . A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus. Immunology 2003; 109:326\u2013328.","journal-title":"Immunology"},{"key":"BFcr2008294_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0022-2836(03)00865-9","volume":"331","author":"EJ Snijder","year":"2003","unstructured":"Snijder EJ, Bredenbeek PJ, Dobbe JC, et al. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 2003; 331:991\u20131004.","journal-title":"J Mol Biol"},{"key":"BFcr2008294_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(03)13973-6","volume":"362","author":"J Cinatl","year":"2003","unstructured":"Cinatl J, Morgenstern B, Bauer G, et al. Treatment of SARS with human interferons. Lancet 2003; 362:293\u2013294.","journal-title":"Lancet"},{"key":"BFcr2008294_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1089\/1079990041535610","volume":"24","author":"B Zheng","year":"2004","unstructured":"Zheng B, He ML, Wong KL, et al. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha\/beta) but not by type II interferon (IFN-gamma). J Interferon Cytokine Res 2004; 24:388\u2013390.","journal-title":"J Interferon Cytokine Res"},{"key":"BFcr2008294_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2172-6-2","volume":"6","author":"R Reghunathan","year":"2005","unstructured":"Reghunathan R, Jayapal M, Hsu LY, et al. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol 2005; 6:2.","journal-title":"BMC Immunol"},{"key":"BFcr2008294_CR6","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.immunol.25.022106.141706","volume":"25","author":"J Chen","year":"2007","unstructured":"Chen J, Subbarao K . The immunobiology of SARS*. Annu Rev Immunol 2007; 25:443\u2013472.","journal-title":"Annu Rev Immunol"},{"key":"BFcr2008294_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virusres.2007.03.015","volume":"133","author":"M Frieman","year":"2007","unstructured":"Frieman M, Heise M, Baric R . SARS coronavirus and innate immunity. Virus Res 2007; 133:101\u2013112.","journal-title":"Virus Res"},{"key":"BFcr2008294_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1128\/JVI.01512-06","volume":"81","author":"H Zhou","year":"2007","unstructured":"Zhou H, Perlman S . Mouse hepatitis virus does not induce Beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J Virol 2007; 81:568\u2013574.","journal-title":"J Virol"},{"key":"BFcr2008294_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.virol.2007.01.020","volume":"361","author":"GA Versteeg","year":"2007","unstructured":"Versteeg GA, Bredenbeek PJ, van den Worm SH, Spaan WJ . Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 2007; 361:18\u201326.","journal-title":"Virology"},{"key":"BFcr2008294_CR10","doi-asserted-by":"publisher","first-page":"11620","DOI":"10.1128\/JVI.00702-07","volume":"81","author":"MG Wathelet","year":"2007","unstructured":"Wathelet MG, Orr M, Frieman MB, Baric RS . Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J Virol 2007; 81:11620\u201311633.","journal-title":"J Virol"},{"key":"BFcr2008294_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/JVI.01782-06","volume":"81","author":"SA Kopecky-Bromberg","year":"2007","unstructured":"Kopecky-Bromberg SA, Martinez-Sobrido L, Frieman M, Baric RA, Palese P . Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 2007; 81:548\u2013557.","journal-title":"J Virol"},{"key":"BFcr2008294_CR12","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s00109-006-0084-y","volume":"84","author":"S Uematsu","year":"2006","unstructured":"Uematsu S, Akira S . Toll-like receptors and innate immunity. J Mol Med 2006; 84:712\u2013725.","journal-title":"J Mol Med"},{"key":"BFcr2008294_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/sj.cr.7290309","volume":"15","author":"AK Perry","year":"2005","unstructured":"Perry AK, Chen G, Zheng D, Tang H, Cheng G . The host type I interferon response to viral and bacterial infections. Cell Res 2005; 15:407\u2013422.","journal-title":"Cell Res"},{"key":"BFcr2008294_CR14","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/ni1087","volume":"5","author":"M Yoneyama","year":"2004","unstructured":"Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5:730\u2013737.","journal-title":"Nat Immunol"},{"key":"BFcr2008294_CR15","doi-asserted-by":"publisher","first-page":"17264","DOI":"10.1073\/pnas.0407639101","volume":"101","author":"J Andrejeva","year":"2004","unstructured":"Andrejeva J, Childs KS, Young DF, et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc Natl Acad Sci USA 2004; 101:17264\u201317269.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr2008294_CR16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nature04374","volume":"439","author":"G Oganesyan","year":"2006","unstructured":"Oganesyan G, Saha SK, Guo B, et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 2006; 439:208\u2013211.","journal-title":"Nature"},{"key":"BFcr2008294_CR17","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1038\/sj.emboj.7601220","volume":"25","author":"SK Saha","year":"2006","unstructured":"Saha SK, Pietras EM, He JQ, et al. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. Embo J 2006; 25:3257\u20133263.","journal-title":"Embo J"},{"key":"BFcr2008294_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/107999099314360","volume":"19","author":"J Hiscott","year":"1999","unstructured":"Hiscott J, Pitha P, Genin P, et al. Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res 1999; 19:1\u201313.","journal-title":"J Interferon Cytokine Res"},{"key":"BFcr2008294_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","volume":"19","author":"T Taniguchi","year":"2001","unstructured":"Taniguchi T, Ogasawara K, Takaoka A, Tanaka N . IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001; 19:623\u2013655.","journal-title":"Annu Rev Immunol"},{"key":"BFcr2008294_CR20","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05732","volume":"446","author":"MU Gack","year":"2007","unstructured":"Gack MU, Shin YC, Joo CH, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007; 446:916\u2013920.","journal-title":"Nature"},{"key":"BFcr2008294_CR21","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1126\/science.1145918","volume":"318","author":"N Kayagaki","year":"2007","unstructured":"Kayagaki N, Phung Q, Chan S, et al. DUBA: a deubiquitinase that regulates type I interferon production. Science 2007; 318:1628\u20131632.","journal-title":"Science"},{"key":"BFcr2008294_CR22","doi-asserted-by":"publisher","first-page":"15189","DOI":"10.1128\/JVI.79.24.15189-15198.2005","volume":"79","author":"N Barretto","year":"2005","unstructured":"Barretto N, Jukneliene D, Ratia K, et al. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol 2005; 79:15189\u201315198.","journal-title":"J Virol"},{"key":"BFcr2008294_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2005.04.010","volume":"23","author":"H Kato","year":"2005","unstructured":"Kato H, Sato S, Yoneyama M, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005; 23:19\u201328.","journal-title":"Immunity"},{"key":"BFcr2008294_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","volume":"441","author":"H Kato","year":"2006","unstructured":"Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101\u2013105.","journal-title":"Nature"},{"key":"BFcr2008294_CR25","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","volume":"77","author":"CF Basler","year":"2003","unstructured":"Basler CF, Mikulasova A, Martinez-Sobrido L, et al. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 2003; 77:7945\u20137956.","journal-title":"J Virol"},{"key":"BFcr2008294_CR26","doi-asserted-by":"publisher","first-page":"7989","DOI":"10.1128\/JVI.74.17.7989-7996.2000","volume":"74","author":"J Talon","year":"2000","unstructured":"Talon J, Horvath CM, Polley R, et al. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 2000; 74:7989\u20137996.","journal-title":"J Virol"},{"key":"BFcr2008294_CR27","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/nature04193","volume":"437","author":"E Meylan","year":"2005","unstructured":"Meylan E, Curran J, Hofmann K, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005; 437:1167\u20131172.","journal-title":"Nature"},{"key":"BFcr2008294_CR28","doi-asserted-by":"publisher","first-page":"32208","DOI":"10.1074\/jbc.M704870200","volume":"282","author":"SG Devaraj","year":"2007","unstructured":"Devaraj SG, Wang N, Chen Z, et al. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J Biol Chem 2007; 282:32208\u201332221.","journal-title":"J Biol Chem"},{"key":"BFcr2008294_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ni1118","volume":"5","author":"T Kawai","year":"2004","unstructured":"Kawai T, Sato S, Ishii KJ, et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5:1061\u20131068.","journal-title":"Nat Immunol"},{"key":"BFcr2008294_CR30","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1128\/MCB.02256-06","volume":"27","author":"LE Huye","year":"2007","unstructured":"Huye LE, Ning S, Kelliher M, Pagano JS . Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol Cell Biol 2007; 27:2910\u20132918.","journal-title":"Mol Cell Biol"},{"key":"BFcr2008294_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/ni1347","volume":"7","author":"T Saitoh","year":"2006","unstructured":"Saitoh T, Tun-Kyi A, Ryo A, et al. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 2006; 7:598\u2013605.","journal-title":"Nat Immunol"},{"key":"BFcr2008294_CR32","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.4049\/jimmunol.177.8.5059","volume":"177","author":"A Bibeau-Poirier","year":"2006","unstructured":"Bibeau-Poirier A, Gravel SP, Clement JF, et al. Involvement of the IkappaB kinase (IKK)-related kinases tank-binding kinase 1\/IKKi and cullin-based ubiquitin ligases in IFN regulatory factor-3 degradation. J Immunol 2006; 177:5059\u20135067.","journal-title":"J Immunol"},{"key":"BFcr2008294_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbamcr.2004.09.019","volume":"1695","author":"CM Pickart","year":"2004","unstructured":"Pickart CM, Eddins MJ . Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta 2004; 1695:55\u201372.","journal-title":"Biochim Biophys Acta"},{"key":"BFcr2008294_CR34","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/sj.emboj.7601061","volume":"25","author":"M Wang","year":"2006","unstructured":"Wang M, Cheng D, Peng J, Pickart CM . Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase. Embo J 2006; 25:1710\u20131719.","journal-title":"Embo J"},{"key":"BFcr2008294_CR35","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1111\/j.1462-5822.2007.00990.x","volume":"9","author":"CR Sweet","year":"2007","unstructured":"Sweet CR, Conlon J, Golenbock DT, Goguen J, Silverman N . YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction. Cell Microbiol 2007; 9:2700\u20132715.","journal-title":"Cell Microbiol"},{"key":"BFcr2008294_CR36","doi-asserted-by":"publisher","first-page":"11065","DOI":"10.1128\/JVI.76.21.11065-11078.2002","volume":"76","author":"B Yount","year":"2002","unstructured":"Yount B, Denison MR, Weiss SR, Baric RS . Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J Virol 2002; 76:11065\u201311078.","journal-title":"J Virol"},{"key":"BFcr2008294_CR37","doi-asserted-by":"publisher","first-page":"7911","DOI":"10.1128\/JVI.74.17.7911-7921.2000","volume":"74","author":"A Kanjanahaluethai","year":"2000","unstructured":"Kanjanahaluethai A, Baker SC . Identification of mouse hepatitis virus papain-like proteinase 2 activity. J Virol 2000; 74:7911\u20137921.","journal-title":"J Virol"},{"key":"BFcr2008294_CR38","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1084\/jem.20040528","volume":"199","author":"AK Perry","year":"2004","unstructured":"Perry AK, Chow EK, Goodenough JB, Yeh WC, Cheng G . Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J Exp Med 2004; 199:1651\u20131658.","journal-title":"J Exp Med"},{"key":"BFcr2008294_CR39","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1523\/JNEUROSCI.4474-04.2005","volume":"25","author":"KL Lim","year":"2005","unstructured":"Lim KL, Chew KC, Tan JM, et al. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J Neurosci 2005; 25:2002\u20132009.","journal-title":"J Neurosci"},{"key":"BFcr2008294_CR40","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gnh110","volume":"32","author":"L Zheng","year":"2004","unstructured":"Zheng L, Baumann U, Reymond JL . An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res 2004; 32:e115.","journal-title":"Nucleic Acids Res"},{"key":"BFcr2008294_CR41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/JVI.33.1.449-462.1980","volume":"33","author":"LS Sturman","year":"1980","unstructured":"Sturman LS, Holmes KV, Behnke J . Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J Virol 1980; 33:449\u2013462.","journal-title":"J Virol"},{"key":"BFcr2008294_CR42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/JVI.73.1.638-649.1999","volume":"73","author":"RS Baric","year":"1999","unstructured":"Baric RS, Sullivan E, Hensley L, Yount B, Chen W . Persistent infection promotes cross-species transmissibility of mouse hepatitis virus. J Virol 1999; 73:638\u2013649.","journal-title":"J Virol"},{"key":"BFcr2008294_CR43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4049\/jimmunol.49.2.87","volume":"49","author":"JE Salk","year":"1944","unstructured":"Salk JE . A Simplified Procedure for Titrating Hemagglutinating Capacity of Influenza-Virus and the Corresponding Antibody. J Immunol 1944; 49:87\u201398.","journal-title":"J Immunol"},{"key":"BFcr2008294_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1074-7613(02)00390-4","volume":"17","author":"S Doyle","year":"2002","unstructured":"Doyle S, Vaidya S, O'Connell R, et al. IRF3 mediates a TLR3\/TLR4-specific antiviral gene program. Immunity 2002; 17:251\u2013263.","journal-title":"Immunity"},{"key":"BFcr2008294_CR45","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.4049\/jimmunol.170.7.3565","volume":"170","author":"SE Doyle","year":"2003","unstructured":"Doyle SE, O'Connell R, Vaidya SA, et al. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4. J Immunol 2003; 170:3565\u20133571.","journal-title":"J Immunol"},{"key":"BFcr2008294_CR46","doi-asserted-by":"publisher","first-page":"10491","DOI":"10.1074\/jbc.M412819200","volume":"280","author":"C Weng","year":"2005","unstructured":"Weng C, Li Y, Xu D, Shi Y, Tang H . Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J Biol Chem 2005; 280:10491\u201310500.","journal-title":"J Biol Chem"},{"key":"BFcr2008294_CR47","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1074\/jbc.M510326200","volume":"281","author":"R Lin","year":"2006","unstructured":"Lin R, Yang L, Nakhaei P, et al. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem 2006; 281:2095\u20132103.","journal-title":"J Biol Chem"},{"key":"BFcr2008294_CR48","doi-asserted-by":"publisher","first-page":"11817","DOI":"10.1074\/jbc.M700017200","volume":"282","author":"B Guo","year":"2007","unstructured":"Guo B, Cheng G . Modulation of the interferon antiviral response by the TBK1\/IKKi adaptor protein TANK. J Biol Chem 2007; 282:11817\u201311826.","journal-title":"J Biol Chem"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cr2008294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr2008294","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr2008294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:30:25Z","timestamp":1684607425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr2008294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,28]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["BFcr2008294"],"URL":"https:\/\/doi.org\/10.1038\/cr.2008.294","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,28]]}}}